About EquineBiotech
EquineBiotech is a company based in Bengaluru (India) founded in 2023. It operates as a B2B. EquineBiotech operates in a competitive market with competitors including Alveo Technologies, Anavasi Diagnostics, Luas Diagnostics, Snibe and VIRIS Detection Systems, among others.
- Headquarter Bengaluru, India
- SectorsHealthcare
- Website equinebiotech.org
- Annual Revenue$307.85 K (USD)0as on Mar 31, 2022
Competitors of EquineBiotech
EquineBiotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alveo Technologies, Anavasi Diagnostics, Luas Diagnostics, Snibe and VIRIS Detection Systems, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| alveotechnologies.com | 2014 | Alameda, United States | $63.61M | – | Cloud-powered POC MDx device | |
| anavasidx.com | 2020 | Seattle, United States | $6M | – | Molecular detectors for COVID-19 detection are manufactured. | |
| luasdiagnostics.com | 2020 | Guildford, United Kingdom | $949,082 | 3 | Sensors and connected app are developed for diabetes management. | |
| snibe.com | 1995 | Shenzhen, China | – | – | Developer of laboratory analysis equipment and reagents | |
| virisdetectionsystems.com | 2020 | Denver, United States | – | – | CRISPR-based RNA-guided diagnostics for SARS-CoV-2 detection are developed. | |
| biohermes.com | 2007 | Wuxi, China | – | – | Provider of POC diagnostic devices and kits | |
| dxlab.bio | 2020 | Somerville, United States | – | – | Point-of-care devices for infectious disease detection are developed. | |
| oxsed.com | 2020 | United Kingdom | – | 9 | Diagnostics solutions for COVID-19 infections are provided using RT-LAMP technology. |
Detailed competitors of EquineBiotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to EquineBiotech
10 companies that operate in the same segment as EquineBiotech (Infectious Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Clinical diagnostics and drug discovery for immune diseases are provided. | 2009 | Seattle, Washington, United States | USD 419.15 M | USD 276.98 M | 619 | |
Vaccines for infectious diseases are developed using cell-free protein synthesis. | 2013 | Foster City, California, United States | USD 347 M | – | 414 | |
Portable PCR diagnostics for infectious diseases are developed. | 2010 | San Jose, California, United States | USD 386.33 M | – | – | |
Developing glucan synthase inhibitors for the treatment of fungal infections. | 1999 | Jersey City, New Jersey, United States | USD 62.65 M | USD 20.6 M | 28 | |
Sherlock Biosciences is focused on molecular diagnostics development. | 2019 | Watertown, United States | USD 111 M | – | 33 | |
Provider of diagnostic solutions for systemic infections | 2016 | San Francisco, California, United States | USD 191.47 M | – | 54 | |
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EquineBiotech
EquineBiotech was founded in 2023.
EquineBiotech is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Annual revenue of EquineBiotech is $307.85K as on Mar 31, 2022.
EquineBiotech, established in 2023 and currently in Dissolved stage, focuses on providing healthcare solutions, advancing biotech innovations, offering diagnostic solutions, and infectious disease testing. Provides comprehensive diagnostic test kits for detecting infectious diseases. Adapting to market demands with innovation and client-focused strategies.
EquineBiotech's top competitors include Alveo Technologies, Snibe and DxLab.